表紙
市場調查報告書
商品編碼
1028181

難辨梭狀芽孢桿菌治療藥的全球市場(2021年∼2025年)

Global Clostridium Difficile Treatment Market 2021-2025

出版日期: | 出版商: TechNavio (Infiniti Research Ltd.) | 英文 120 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

難辨梭狀芽孢桿菌治療藥的市場規模在2021年∼2025年的預測期間內,預計將以約5%的年複合成長率推移,並成長到2億5,354萬美元。

難辨梭狀芽孢桿菌治療藥市場相關之本報告提供整體分析,市場規模與預測,趨勢,涵括成長要素,課題,以及約25位供應商的供應商分析。

該市場成長的主要因素有後期開發分子的臨時批准、新療法的開發和人口老齡化。

本報告提供難辨梭狀芽孢桿菌治療藥市場調查,提供市場概要,市場規模,市場預測,客戶形勢,各產品·各地區的分析,再加上業者情勢和供應商分析等資訊。

目錄

摘要整理

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2020年
  • 市場預測:從2020年∼2025年的預測

波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 競爭的威脅
  • 市場情況

各產品的市場區隔

  • 市場區隔
  • 各產品比較
  • 廣域抗生素:市場規模與預測(2020年∼2025年)
  • 狹階段抗生素:市場規模與預測(2020年∼2025年)
  • 各產品的市場機會

客戶形勢

  • 客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2020年∼2025年)
  • 歐洲:市場規模與預測(2020年∼2025年)
  • 亞洲:市場規模與預測(2020年∼2025年)
  • 其他地區:市場規模與預測(2020年∼2025年)
  • 主要國家
  • 各地區形勢市場機會
  • 市場成長促進因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Aristo Pharmaceuticals Pvt Ltd.
  • AstraZeneca Plc
  • Baxter International Inc.
  • Ferring Pharmaceuticals AS
  • Immuron Ltd.
  • Merck and Co. Inc.
  • Pfizer Inc.
  • Summit Therapeutics Plc
  • Takeda Pharmaceutical Co. Ltd.
  • Zeria Pharmaceutical Co. Ltd.

附錄

目錄
Product Code: IRTNTR44655

Technavio has been monitoring the Clostridium difficile treatment market and it is poised to grow by $ 253.54 mn during 2021-2025, progressing at a CAGR of about 5% during the forecast period. Our report on Clostridium difficile treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by tentative approval of late-stage molecules, development of novel therapies, and rise in aging population. In addition, tentative approval of late-stage molecules is anticipated to boost the growth of the market as well.

The clostridium difficile treatment market analysis includes the product segment and geographic landscape.

Technavio's clostridium difficile treatment market is segmented as below:

By Product

  • Broad spectrum antibiotics
  • Narrow spectrum antibiotics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the emergence of vaccines as one of the prime reasons driving the clostridium difficile treatment market growth during the next few years. Also, special regulatory designations to speed up drug development and high investments in research and development will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on clostridium difficile treatment market covers the following areas:

  • Clostridium difficile treatment market sizing
  • Clostridium difficile treatment market forecast
  • Clostridium difficile treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clostridium difficile treatment market vendors that include Aristo Pharmaceuticals Pvt Ltd., AstraZeneca Plc, Baxter International Inc., Ferring Pharmaceuticals AS, Immuron Ltd., Merck and Co. Inc., Pfizer Inc., Summit Therapeutics Plc, Takeda Pharmaceutical Co. Ltd., and Zeria Pharmaceutical Co. Ltd. Also, the clostridium difficile treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Product
    • Market segments
    • Comparison by Product
    • Broad spectrum antibiotics - Market size and forecast 2020-2025
    • Narrow spectrum antibiotics - Market size and forecast 2020-2025
    • Market opportunity by Product
  • Customer landscape
    • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Aristo Pharmaceuticals Pvt Ltd.
    • AstraZeneca Plc
    • Baxter International Inc.
    • Ferring Pharmaceuticals AS
    • Immuron Ltd.
    • Merck and Co. Inc.
    • Pfizer Inc.
    • Summit Therapeutics Plc
    • Takeda Pharmaceutical Co. Ltd.
    • Zeria Pharmaceutical Co. Ltd.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Broad spectrum antibiotics - Market size and forecast 2020-2025 ($ million)
  • 24: Broad spectrum antibiotics - Year-over-year growth 2020-2025 (%)
  • 25: Narrow spectrum antibiotics - Market size and forecast 2020-2025 ($ million)
  • 26: Narrow spectrum antibiotics - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share By Geographical Landscape 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity By Geographical Landscape ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Aristo Pharmaceuticals Pvt Ltd. - Overview
  • 48: Aristo Pharmaceuticals Pvt Ltd. - Product and service
  • 49: Aristo Pharmaceuticals Pvt Ltd. - Key offerings
  • 50: Aristo Pharmaceuticals Pvt Ltd. - Key customers
  • 51: Aristo Pharmaceuticals Pvt Ltd. - Segment focus
  • 52: AstraZeneca Plc - Overview
  • 53: AstraZeneca Plc - Product and service
  • 54: AstraZeneca Plc - Key offerings
  • 55: AstraZeneca Plc - Key customers
  • 56: AstraZeneca Plc - Segment focus
  • 57: Baxter International Inc. - Overview
  • 58: Baxter International Inc. - Business segments
  • 59: Baxter International Inc. - Key offerings
  • 60: Baxter International Inc. - Key customers
  • 61: Baxter International Inc. - Segment focus
  • 62: Ferring Pharmaceuticals AS - Overview
  • 63: Ferring Pharmaceuticals AS - Product and service
  • 64: Ferring Pharmaceuticals AS - Key offerings
  • 65: Ferring Pharmaceuticals AS - Key customers
  • 66: Ferring Pharmaceuticals AS - Segment focus
  • 67: Immuron Ltd. - Overview
  • 68: Immuron Ltd. - Business segments
  • 69: Immuron Ltd. - Key offerings
  • 70: Immuron Ltd. - Key customers
  • 71: Immuron Ltd. - Segment focus
  • 72: Merck and Co. Inc. - Overview
  • 73: Merck and Co. Inc. - Business segments
  • 74: Merck and Co. Inc. - Key offerings
  • 75: Merck and Co. Inc. - Key customers
  • 76: Merck and Co. Inc. - Segment focus
  • 77: Pfizer Inc. - Overview
  • 78: Pfizer Inc. - Business segments
  • 79: Pfizer Inc. - Key offerings
  • 80: Pfizer Inc. - Key customers
  • 81: Pfizer Inc. - Segment focus
  • 82: Summit Therapeutics Plc - Overview
  • 83: Summit Therapeutics Plc - Business segments
  • 84: Summit Therapeutics Plc - Key offerings
  • 85: Summit Therapeutics Plc - Key customers
  • 86: Summit Therapeutics Plc - Segment focus
  • 87: Takeda Pharmaceutical Co. Ltd. - Overview
  • 88: Takeda Pharmaceutical Co. Ltd. - Product and service
  • 89: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 90: Takeda Pharmaceutical Co. Ltd. - Key customers
  • 91: Takeda Pharmaceutical Co. Ltd. - Segment focus
  • 92: Zeria Pharmaceutical Co. Ltd. - Overview
  • 93: Zeria Pharmaceutical Co. Ltd. - Product and service
  • 94: Zeria Pharmaceutical Co. Ltd. - Key offerings
  • 95: Zeria Pharmaceutical Co. Ltd. - Key customers
  • 96: Zeria Pharmaceutical Co. Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations